OUTREACH CLINICAL TRIALS
Live / Applied — Ex parte appeal pending (as of 03 Feb 2026)
What this means for you
Not registered yet, but its 12 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98900521
- Mark type
- Stylized text
- Filed
- 12 Dec 2024
Goods and services
- Class 042 — Scientific and technological services: Consulting services for others in the field of design, planning, and implementation project management of clinical trials, scientific research and underrepresented community engagement
Owner
- Outreach Clinical Trials LLC, Washington, DC, US
Prosecution history
- 02 Feb 2026 — NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
- 02 Feb 2026 — ACTION DENYING REQ FOR RECON E-MAILED
- 02 Feb 2026 — ACTION CONTINUING FINAL - COMPLETED
- 18 Dec 2025 — EX PARTE APPEAL-INSTITUTED
- 18 Dec 2025 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 18 Dec 2025 — EXPARTE APPEAL RECEIVED AT TTAB
- 17 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Dec 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 05 Nov 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 05 Nov 2025 — FINAL REFUSAL E-MAILED
- 05 Nov 2025 — FINAL REFUSAL WRITTEN
- 06 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED